Bellerophon Therapeutics Inc (NASDAQ:BLPH)

3.84
Delayed Data
As of Oct 25
 0.00 / 0.00%
Today’s Change
3.66
Today|||52-Week Range
9.75
-42.43%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Bellerophon Therapeutics Inc have a median target of 28.00, with a high estimate of 30.00 and a low estimate of 26.00. The median estimate represents a +629.17% increase from the last price of 3.84.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Bellerophon Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.63
Sales
$0.00
Reporting Date
Nov 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -76.86%
 
 
 
 
 
 
Growthannually 29.97%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.